Filed: 11/14/2023ACC: 0001123292-23-000142
📋 What this filing means
ATHYRIUM CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $113.56M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$113.56M
Total AUM (reported)
164.81M
Total Shares
Allocation by class
NOTE 5.250% 2/1$44.64M39.3%
NOTE 7.250% 12/0$27.96M24.6%
COM NEW$23.72M20.9%
NOTE 6.250%11/1$11.26M9.9%
COM$4.71M4.2%
SHS$1.26M1.1%
Portfolio Concentration
Top 3$96.32M84.8%
4–10$17.23M15.2%
Top 3 weight
84.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 164.81M
Sole
Full voting authority
27.32M
shares
% of voting shares16.6%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
137.48M
shares
% of voting shares83.4%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeNone · 83.4% of voting shares
Institutional Holdings6
Rows:
Omeros Corp
SOLEShares72.98M
TypePRN
Market value$44.64M
39.31%
Sole
0.00
Shared
0.00
None
72.98M
Biora Inc.
SOLEShares53.50M
TypePRN
Market value$27.96M
24.62%
Sole
0.00
Shared
0.00
None
53.50M
Biora Inc.
SOLEShares10.93M
TypeSH
Market value$23.72M
20.89%
Sole
10.93M
Shared
0.00
None
0.00
Omeros Corp
SOLEShares11.01M
TypePRN
Market value$11.26M
9.91%
Sole
0.00
Shared
0.00
None
11.01M
PUMA BIOTECHNOLOGY INC
SOLEShares1.79M
TypeSH
Market value$4.71M
4.15%
Sole
1.79M
Shared
0.00
None
0.00
RVL PHARMACEUTICALS PLC
SOLEShares14.60M
TypeSH
Market value$1.26M
1.11%
Sole
14.60M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Omeros CorpSOLE | NOTE 5.250% 2/1 | 72.98M | PRN | $44.64M 39.31% | 0.00 | 0.00 | 72.98M |
Biora Inc.SOLE | Note 7.250% 12/0 | 53.50M | PRN | $27.96M 24.62% | 0.00 | 0.00 | 53.50M |
Biora Inc.SOLE | COM NEW | 10.93M | SH | $23.72M 20.89% | 10.93M | 0.00 | 0.00 |
Omeros CorpSOLE | NOTE 6.250%11/1 | 11.01M | PRN | $11.26M 9.91% | 0.00 | 0.00 | 11.01M |
PUMA BIOTECHNOLOGY INCSOLE | COM | 1.79M | SH | $4.71M 4.15% | 1.79M | 0.00 | 0.00 |
RVL PHARMACEUTICALS PLCSOLE | SHS | 14.60M | SH | $1.26M 1.11% | 14.60M | 0.00 | 0.00 |